TARS vs. ALKS

Last updated Apr 1, 2026

Compare and contrast key facts about Tarsus Pharmaceuticals, Inc. (TARS) and Alkermes plc (ALKS).

Performance

TARS vs. ALKS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tarsus Pharmaceuticals, Inc. (TARS) and Alkermes plc (ALKS). The values are adjusted to include any dividend payments, if applicable.

TARS vs. ALKS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
TARS Tarsus Pharmaceuticals, Inc.	-14.33%	47.88%	173.43%	38.13%	-34.84%	-45.56%	100.83%
ALKS Alkermes plc	26.38%	-2.71%	3.68%	6.16%	12.34%	16.59%	16.46%

Fundamentals

Market Cap TARS : $3.00B ALKS : $5.97B
EPS TARS : -$1.56 ALKS : $1.43
PS Ratio TARS : 6.62 ALKS : 4.04
PB Ratio TARS : 8.74 ALKS : 3.28
Total Revenue (TTM) TARS : $451.36M ALKS : $1.48B
Gross Profit (TTM) TARS : $420.68M ALKS : $1.85B
EBITDA (TTM) TARS : -$60.20M ALKS : $253.96M

Returns By Period

In the year-to-date period, TARS achieves a -14.33% return, which is significantly lower than ALKS's 26.38% return.

TARS

• 1D: 4.83%
• 1M: -7.11%
• YTD: -14.33%
• 6M: 18.04%
• 1Y: 36.56%
• 3Y*: 77.38%
• 5Y*: 16.33%
• 10Y*: —

ALKS

• 1D: 17.28%
• 1M: 17.48%
• YTD: 26.38%
• 6M: 17.87%
• 1Y: 7.09%
• 3Y*: 7.85%
• 5Y*: 13.05%
• 10Y*: -0.09%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

TARS vs. ALKS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TARS

TARS Risk / Return Rank: 67
TARS Sharpe Ratio Rank: 69
TARS Sortino Ratio Rank: 67
TARS Omega Ratio Rank: 62
TARS Calmar Ratio Rank: 69
TARS Martin Ratio Rank: 65

ALKS

ALKS Risk / Return Rank: 46
ALKS Sharpe Ratio Rank: 48
ALKS Sortino Ratio Rank: 44
ALKS Omega Ratio Rank: 43
ALKS Calmar Ratio Rank: 49
ALKS Martin Ratio Rank: 47

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TARS vs. ALKS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tarsus Pharmaceuticals, Inc. (TARS) and Alkermes plc (ALKS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TARS	ALKS	Difference
Sharpe ratio Return per unit of total volatility	0.81	0.18	+0.63
Sortino ratio Return per unit of downside risk	1.46	0.55	+0.91
Omega ratio Gain probability vs. loss probability	1.17	1.07	+0.10
Calmar ratio Return relative to maximum drawdown	1.35	0.29	+1.06
Martin ratio Return relative to average drawdown	2.68	0.51	+2.17
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TARS vs. ALKS - Sharpe Ratio Comparison

The current TARS Sharpe Ratio is 0.81, which is higher than the ALKS Sharpe Ratio of 0.18. The chart below compares the historical Sharpe Ratios of TARS and ALKS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	TARS	ALKS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.81	0.18	+0.63
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.27	0.36	-0.08
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.00	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.39	0.09	+0.30

Correlation

The correlation between TARS and ALKS is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

TARS vs. ALKS - Dividend Comparison

Neither TARS nor ALKS has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

TARS vs. ALKS - Drawdown Comparison

The maximum TARS drawdown since its inception was -77.67%, smaller than the maximum ALKS drawdown of -96.14%. Use the drawdown chart below to compare losses from any high point for TARS and ALKS.

Drawdown Indicators

	TARS	ALKS	Difference
Max Drawdown Largest peak-to-trough decline	-77.67%	-96.14%	+18.47%
Max Drawdown (1Y) Largest decline over 1 year	-26.34%	-22.20%	-4.14%
Max Drawdown (5Y) Largest decline over 5 years	-71.29%	-33.18%	-38.11%
Max Drawdown (10Y) Largest decline over 10 years	—	-80.58%	—
Current Drawdown Current decline from peak	-14.98%	-63.94%	+48.96%
Average Drawdown Average peak-to-trough decline	-41.22%	-67.27%	+26.05%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.30%	12.67%	+0.63%

Volatility

TARS vs. ALKS - Volatility Comparison

The current volatility for Tarsus Pharmaceuticals, Inc. (TARS) is 11.44%, while Alkermes plc (ALKS) has a volatility of 18.64%. This indicates that TARS experiences smaller price fluctuations and is considered to be less risky than ALKS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TARS	ALKS	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.44%	18.64%	-7.20%
Volatility (6M) Calculated over the trailing 6-month period	30.30%	30.05%	+0.25%
Volatility (1Y) Calculated over the trailing 1-year period	45.38%	40.45%	+4.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.97%	36.83%	+23.14%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	64.52%	41.37%	+23.15%

Financials